Lv11
46 积分 2026-07-20 加入
Beyond HFmrEF: New Classification, Unchanged Treatment Evidence
2小时前
已关闭
Elevated levels of Activin A in heart failure: potential role in myocardial remodeling
2天前
已关闭
Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer
20天前
已完结
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
20天前
已完结
Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase‑2 (ALK2) for the Treatment of Fibrodysplasia Ossificans Progressiva
1个月前
已完结
Preclinical in vitro evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibody
1个月前
已关闭
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
2个月前
已完结
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
2个月前
已完结
The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway
2个月前
已完结
皖公网安备34019202002308
